DOCSLIB.ORG

Dermatological Indications for the Use of Isotretinoin Beyond Acne

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dermatological Indications for the Use of Isotretinoin Beyond Acne Journal of Dermatological Treatment ISSN: 0954-6634 (Print) 1471-1753 (Online) Journal homepage: https://www.tandfonline.com/loi/ijdt20 Dermatological indications for the use of isotretinoin beyond acne Emily Forbat, Faisal R. Ali & Firas Al-Niaimi To cite this article: Emily Forbat, Faisal R. Ali & Firas Al-Niaimi (2018) Dermatological indications for the use of isotretinoin beyond acne, Journal of Dermatological Treatment, 29:7, 698-705, DOI: 10.1080/09546634.2018.1445194 To link to this article: https://doi.org/10.1080/09546634.2018.1445194 Accepted author version posted online: 26 Feb 2018. Published online: 14 Mar 2018. Submit your article to this journal Article views: 503 View related articles View Crossmark data Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=ijdt20 JOURNAL OF DERMATOLOGICAL TREATMENT 2018, VOL. 29, NO. 7, 698–705 https://doi.org/10.1080/09546634.2018.1445194 REVIEW ARTICLE Dermatological indications for the use of isotretinoin beyond acne Emily Forbata, Faisal R. Alib and Firas Al-Niaimib aChelsea and Westminster Hospital, London, UK; bDermatological Surgery & Laser Unit, St John’s Institute of Dermatology, Guy’s Cancer Centre, Guy’s and St Thomas’ NHS Foundation Trust, London, UK ABSTRACT ARTICLE HISTORY While the use of isotretinoin has revolutionized the treatment of acne vulgaris, isotretinoin is increasingly Received 3 February 2018 recognized as a useful therapeutic option for many other cutaneous conditions. We review the evidence Accepted 14 February 2018 underlying the use of isotretinoin for a variety of dermatological indications including hidradenitis suppu- KEYWORDS rativa, sebaceous gland pathology, rosacea, scarring alopecia, cosmetic dermatology, and non-melanoma skin cancer prophylaxis amongst other uses, and thus consider alternative uses within dermatology prac- Isotretinoin; retinoids; rosacea; cosmetic tice. The studies found benefit of isotretinoin, however most trials lacked statistical power and in many dermatology; hidradenitis cases the use was limited to case series. Isotretinoin, if used within the correct cohort with appropriate suppurativa pretreatment counseling regarding side-effects, is a well-tolerated medication with potential as either an adjunctive treatment or a second-line agent in those recalcitrant cases unresponsive to first-line therapy. Introduction 33 case studies/case series (6,7,9–39), two retrospective reviews (8,40), six randomized control trials (RCTs) (41–46), two random- Isotretinoin, also known as 13-cis-retinoic acid, is a synthetic drug ized comparative trials (47,48), one open-label non-randomized best known for its treatment of acne (1). The mechanism of action prospective pilot study (49), one retrospective comparison study results from isotretinoin-induced expression of apoptotic protein (50), one single-blind randomized study (51), two case-controlled necrosis factor, and a recent review suggests that apoptosis is the randomized clinical studies (52,53), and one cohort study (54). culprit for the multitude of well-known side-effects of isotretinoin (2). Isotretinoin regulates cell proliferation by binding to nuclear Within these studies, 2996 patients were treated between 1985 retinoic acid receptors. Furthermore, it is said to decrease poly- and 2017 (Table 1). amine synthesis and keratinization which contributes to its anti- inflammatory and anti-prolific properties (3). Isotretinoin was first Hidradenitis suppurativa approved for the treatment of acne in 1982 (4). The UK license for isotretinoin was first established in 2001, and the European direct- A retrospective review has been carried out assessing the use of ive advises the treatment of acne to start at a dose of 0.5 mg/kg isotretinoin for the treatment of hidradenitis suppurativa (HS) (39). and be avoided in children under 12 years old, with strict preg- There have been a multitude of papers which refute the benefit nancy prevention strategies. Furthermore, liver function and lipid of isotretinoin in patients with concomitant HS and acne (56,57). monitoring are required to be checked prior to treatment, Treatment with isotretinoin in these cases of dual pathology often 1 month post-initiation of treatment, and 3 months thereafter (5). demonstrated a minimal response of HS, despite both HS and The longest duration of use of isotretinoin from our review was 7 acne both being associated with ductal abnormalities (58). Huang years, in which low-dose isotretinoin was used intermittently to and Kirchhof argue that isotretinoin should not be dismissed, as treat erythema dyschromicum perstans (6). The age range of careful literature evaluation in fact demonstrates that in the cor- patients reviewed in this article varied from just under 7 months rect cohort – i.e. those with mild/moderate HS, females, or con- of age to 64 years old (7,8). comitant acne – complete remission has been achieved (8). Further research is required, as the use of isotretinoin in HS is Method sparse. We conducted a literature search in October 2017, to review the Sebaceous gland pathology current uses of isotretinoin in dermatology beyond the treatment of acne. A PubMed, search was carried out, with the search criteria A randomized comparative trial comparing alternate daily use of ‘Isotretinoin’ & ‘Dermatology’. Only articles published in English 10 mg isotretinoin versus topical anti-seborrheic treatment in were included. Review articles were omitted, unless they specific- moderate to severe seborrhea and seborrheic dermatitis (N ¼ 45) ally analyzed studies within them. Articles on the use of isotreti- over 6 months, demonstrated a significantly greater reduction in noin and acne were also excluded. scalp sebum secretion (p ¼ .004) in the isotretinoin arm after 3 months (47). Patients were not followed-up beyond 3 months and Results the dosage was not weight-dependent. Tagliolatto et al. treated 20 patients with sebaceous hyperplasia with isotretinoin (1 mg/kg Our search identified 1125 studies, of which 49 met the criteria of per day) for 2 months; the average number of skin lesions assessing the use of isotretinoin beyond acne. In total, there were decreased from 24 to 2 per patient (p < .05) (59). Isotretinoin is CONTACT Dr Emily Forbat [email protected] Chelsea and Westminster Hospital, 369 Fulham Rd, London SW10 9NH, UK ß 2018 Informa UK Limited, trading as Taylor & Francis Group Table 1. Studies on the use of isotretinoin beyond acne. Study Indication Aim Patient number Dose Findings Part 1: Inflammatory dermatoses and infectious disorders Inflammatory dermatoses Huang and Kirchhof (8) Hidradenitis A retrospective N ¼ 25 0.45 ± 0.20 mg/kg/day for 6.8 ± 4.3 32% no response, suppurativa chart review months 32% partial response, 36% complete response Rademaker (40) Papulopustular A retrospective N ¼ 52 20 mg isotretinoin/day 12% did not attend follow up. rosacea review reduced to 10–20 mg once to five Those that did attend, 91% (42/46): rosacea cleared or times a week in 67%, was excellent. or One patient stopped due to SE. increased in 15% (who all had add- 44% no SE. itional acne) to 30–40 mg/day The most common SE was cheilitis in 52%, which was mild in all but one patient Sbidian et al. (41) Papulopustular A RCT N ¼ 156 0.25 mg/kg/day Post 4-month treatment at least 90% reduction of pap- rosacea versus ules/papules in comparison to pre-treatment. placebo for 4 months Significantly higher skindex score in treated group versus placebo group. 58.3% of 51 patients who agreed to 4 month FU, demon- strated relapse Rallis and Korfitis (20) Granulomatous A case study N ¼ 1 0.7 mg/kg/day for 24 weeks. 3-month FU: satisfactory rosacea 5-month FU: total remission 6-month post-cessation of treatment: no recurrence. Uslu et al. (22) Rosacea A case series N ¼ 25 20 mg/day for 4 months, tapering the Papule and pustule, erythema index, sebum level, dose within the following 6 months. dermatologist’s and patient’s erythema scores, and dermatologist’s sebum scores: significantly lower, one- month post-therapy versus pre-therapy (p < .05). 45% relapse within median FU of 11 months Gollnick et al. (52) Rosacea Doxycycline- and placebo- N ¼ 573 One of three different dosages of iso- Isotretinoin 0.3 mg/kg most effective dose versus placebo. controlled, randomized tretinoin With IST: clinical study 0.1 mg Complete remission in 24% (14%) 0.3 mg Marked improvement 57% (55%) versus the bracketed fig- 0.5 mg ures for doxycycline (per kg body weight) SE: increase incidence of dermatitis facialis with 0.5 mg/kg þ doxycycline (100 mg daily for 14 days, then 50 mg daily) or placebo JOURNAL OF DERMATOLOGICAL TREATMENT for 12 weeks. Mortazavi et al. (51) Psoriasis vulgaris A single blind N ¼ 37 Intervention group: narrow band ultra- Psoriasis Area Severity Index (PASI) scores demonstrated randomized violet B (NBUVB) þ isotretinoin no significant difference between efficacies of two clinical study (0.5 mg/kg/day) treatments Control group: narrow band ultraviolet But B (NBUVB) þ isotretinoin Isotretinoin þ NBUVB can reduce phototherapy sessions (0.5 mg/kg/day) and cumulative NBUVB dose required. Al-Shobaili and Al- Pustular psoriasis A case study N ¼ 1 Initially started on methotrexate No relapse after methotrexate stopped after the isotreti- Khenaizan (30) 15 mg/week for 6 weeks, (relapsed noin was commenced. when methotrexate was reduced.) Excellent control when isotretinoin continued at 40 mg/ Therefore, day in conjunction with topical steroids. 40 mg/day per oral (0.75 mg/kg/day) isotretinoin was added, and 3 weeks later methotrexate was stopped. Infectious disorders Al-Hamamy, Salman and Plane Warts A case series N ¼ 26 Mean of 0.5 mg/kg/day for 2 months. 73.07% complete response Abdulsattar (19) 26.92% no response at the end of treatment. 78.94% who had complete response, no recurrence at 4- month follow up 699 (continued) Table 1. Continued 700 Study Indication Aim Patient number Dose Findings Georgala et al (44) Condylomata acumi- A randomized Placebo- N ¼ 60 Randomly assignment to receive Group 1: nata of the cervix controlled trial Group 1: isotretinoin, 0.5 mg/kg daily 32.1% responded completely E.
Load more

Recommended publications
  • Steatocystoma-Multiplex.Pdf
    Steatocystoma multiplex Description Steatocystoma multiplex is a skin disorder characterized by the development of multiple noncancerous (benign) cysts known as steatocystomas. These growths begin in the skin's sebaceous glands, which normally produce an oily substance called sebum that lubricates the skin and hair. Steatocystomas are filled with sebum. In affected individuals, steatocystomas typically first appear during adolescence and are found most often on the torso, neck, upper arms, and upper legs. These cysts are usually the only sign of the condition. However, some affected individuals also have mild abnormalities involving the teeth or the fingernails and toenails. Frequency Although the prevalence of steatocystoma multiplex is unknown, it appears to be rare. Causes Steatocystoma multiplex can be caused by mutations in the KRT17 gene. This gene provides instructions for making a protein called keratin 17, which is produced in the nails, the hair follicles, and the skin on the palms of the hands and soles of the feet. It is also found in the skin's sebaceous glands. Keratin 17 partners with a similar protein called keratin 6b to form networks that provide strength and resilience to the skin, nails, and other tissues. The KRT17 gene mutations that cause steatocystoma multiplex alter the structure of keratin 17, preventing it from forming strong, stable networks within cells. The defective keratin network disrupts the growth and function of cells in the skin and nails, including cells that make up the sebaceous glands. These abnormalities lead to the growth of sebum-containing cysts in people with steatocystoma multiplex. However, it is unclear why steatocystomas are typically the only feature of this disorder.
    [Show full text]
  • Steatocystoma Multiplex-A Rare Genetic Disorder: a Case Report and Review of the Literature Pathology Section
    Case Report DOI: 10.7860/JCDR/2012/4691.2698 Steatocystoma Multiplex-A Rare Genetic Disorder: A Case Report and Review of the Literature Pathology Section HEMLATA T. KAMRA, PRADEEP A. GADGIL, AJAY G. OVHAL, RAHUL R. NARKHEDE ABSTRACT is asymptomatic, is a cosmetic threat to the patient . Only a A 17 years old female presented with multiple asymptomatic few cases of the patients with an autosomal dominant mutation, cutaneous cysts all over body, sparing the head and neck who had keratin 17, have been reported. We are reporting here, region. The microscopic examination of the cysts showed the a case of steatocystoma multiplex in a 17 years old female, features of steatocystoma multiplex. This disorder, although it along with its review of literature. Key Words: Steatocystoma, Autosomal dominant, Radiofrequency probe INTRODUCTION On examination, the dermal cysts were found to be round to oval, Steatocystoma multiplex is a rare genetic disorder with an well defined and smooth surfaced, without a punctum and to vary autosomal dominant type of inheritance which usually presents in in diameter from 2-5mm [Table/Fig-1]. The patient gave a history adolescence or is sporadic in nature. Rare cases with an autosomal of similar lesions in her father too. The systemic and the laboratory dominant pattern of inheritance have been published till now [1]. findings were normal. Sonography revealed multiple nodules The disease presents with multiple asymptomatic cysts on the which were oval in shape, which were relatively well marginated axilla, groin, trunk, scrotum and the proximal extremities because and hypoechoic and with a posterior enhancement.
    [Show full text]
  • Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex
    Original Article Journal of Cutaneous Medicine and Surgery 00(0) 1–5 Coexistence of Hidradenitis Suppurativa © The Author(s) 2021 and Steatocystoma Multiplex; Is It a New Article reuse guidelines: Variant of Hidradenitis Suppurativa? sagepub. com/ journals- permissions DOI: 10. 1177/ 1203 4754 2110 10145 journals. sagepub. com/ home/ cms 1 2 Joshua Fletcher , Claudia Posso- De Los Rios , 3 4 Jadranka Jambrosic , and Afsaneh Alavi Abstract Hidradenitis suppurativa and steatocystoma multiplex may coexist in the same patient. The overlap of these 2 conditions could be suggestive of an unrecognized defect in follicular proliferation mutual in the pathogenesis of both conditions. Here we present 5 patients with both hidradenitis suppurativa and steatocystoma multiplex. Recognizing the overlap between these 2 conditions is important for accurate diagnosis, management, and identification of potential surgical candidates, as well as future basic science research. Keywords dermatology, inflammatory dermatoses Introduction its natural history, mimicking both hidradenitis suppura- tiva and acne conglobata.4,10 Hidradenitis suppurative (HS) is a chronic, inflammatory, The overlap of HS and SM, or SMS, could be sugges- recurrent disease affecting the folliculopilosebaceous unit tive of an unrecognized defect in follicular proliferation in the apocrine gland-bearing areas. This leads to comedo- common to both diseases or a mutual genetic link. 1 nes, nodules, abscesses, sinus tracts, and scarring. HS Recognizing this overlap is important for an accurate usually presents in a sporadic or familial fashion, but rare diagnosis, management and identification of potential sur- syndromic forms recognizable for their unique symptom- gical candidates, as well as future basic science research. 2 atology have been described in the literature.
    [Show full text]
  • Pili Torti: a Feature of Numerous Congenital and Acquired Conditions
    Journal of Clinical Medicine Review Pili Torti: A Feature of Numerous Congenital and Acquired Conditions Aleksandra Hoffmann 1 , Anna Wa´skiel-Burnat 1,*, Jakub Z˙ ółkiewicz 1 , Leszek Blicharz 1, Adriana Rakowska 1, Mohamad Goldust 2 , Małgorzata Olszewska 1 and Lidia Rudnicka 1 1 Department of Dermatology, Medical University of Warsaw, Koszykowa 82A, 02-008 Warsaw, Poland; [email protected] (A.H.); [email protected] (J.Z.);˙ [email protected] (L.B.); [email protected] (A.R.); [email protected] (M.O.); [email protected] (L.R.) 2 Department of Dermatology, University Medical Center of the Johannes Gutenberg University, 55122 Mainz, Germany; [email protected] * Correspondence: [email protected]; Tel.: +48-22-5021-324; Fax: +48-22-824-2200 Abstract: Pili torti is a rare condition characterized by the presence of the hair shaft, which is flattened at irregular intervals and twisted 180◦ along its long axis. It is a form of hair shaft disorder with increased fragility. The condition is classified into inherited and acquired. Inherited forms may be either isolated or associated with numerous genetic diseases or syndromes (e.g., Menkes disease, Björnstad syndrome, Netherton syndrome, and Bazex-Dupré-Christol syndrome). Moreover, pili torti may be a feature of various ectodermal dysplasias (such as Rapp-Hodgkin syndrome and Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome). Acquired pili torti was described in numerous forms of alopecia (e.g., lichen planopilaris, discoid lupus erythematosus, dissecting Citation: Hoffmann, A.; cellulitis, folliculitis decalvans, alopecia areata) as well as neoplastic and systemic diseases (such Wa´skiel-Burnat,A.; Zółkiewicz,˙ J.; as cutaneous T-cell lymphoma, scalp metastasis of breast cancer, anorexia nervosa, malnutrition, Blicharz, L.; Rakowska, A.; Goldust, M.; Olszewska, M.; Rudnicka, L.
    [Show full text]
  • Steatocystoma Multiplex Presenting As Acral Subcutaneous Nodules
    374 Letters to the Editor Steatocystoma Multiplex Presenting as Acral Subcutaneous Nodules Teruki Yanagi and Tetsuri Matsumura Department of Dermatology, Tonan Hospital N1W6, Chuo-ku, Sapporo 060-0001, Japan. E-mail: [email protected] Accepted March 20, 2006. Sir, We describe here a case of steatocystoma multiplex presenting as acral subcutaneous nodules. This case is unique due to: (i) acral distribution and (ii) presentation as subcutaneous nodules. As far as we know, there have been only 2 reports of steatocystoma multiplex (SM) occurring in a predominantly acral distribution. CASE REPORT A 47-year-old Japanese housewife was referred to our hospital with asymptomatic subcutaneous nodules on her forearms. She first noticed the subcutaneous nodules 10 years previously, and they had gradually increased in both size and number. They were not as- Fig. 2. Histopathological features. Well-encapsulated subcutaneous cysts with sociated with any pain or tenderness. Her family history infolded walls lined by stratified squamous epithelium without a granular and past clinical history were unremarkable. Physical layer (haematoxylin-eosin (H&E) stain; original magnification, ×10). Inset examination revealed multiple, mobile, well-defined, shows sebaceous gland lobules within the cyst wall. (H&E stain; original elastic-hard, 5–10 mm subcutaneous nodules on the magnification,× 100). flexor surface of the forearms; 8 on the right and 3 on the left (Fig. 1). There were no other lesions except for DISCUSSION the forearms and no nail changes. Clinically, the lesions were initially thought to be multiple lipomas and an This case of SM is unique due to (i) its acral distribu- excisional biopsy was performed to confirm the sus- tion and (ii) presentation as subcutaneous nodules.
    [Show full text]
  • Eruptive Vellus Hair Cysts: Report of a Pediatric Case with Partial Response to Calcipotriene Therapy
    PEDIATRIC DERMATOLOGY Series Editor: Camila K. Janniger, MD Eruptive Vellus Hair Cysts: Report of a Pediatric Case With Partial Response to Calcipotriene Therapy Emel Erkek, MD; Gülcan Saylam Kurtipek, MD; Deniz Duman, MD; Cihat ¸Sanli, MD; Sibel Erdo ˘gan, MD Eruptive vellus hair cysts (EVHCs) are character- the chest and abdomen (Figure 1). Histopathologic ized by asymptomatic, follicular, comedonelike examination of a punch biopsy specimen revealed papules usually located on the anterior chest and an oval cystic structure in the superficial dermis abdomen. We present a pediatric case of EVHC lined with a thin, stratified, squamous epithelium associated with attention deficit hyperactivity of 2 to 3 layers (Figure 2). The cyst wall was noted disorder that partially responded to calcipotriene to include a granular layer at focal areas. The cyst cream within 2 months. Our aim is to refamiliarize lumen contained lamellate keratin flakes and non- clinicians with a common albeit frequently unrec- pigmented vellus-type hairs (Figure 3). In serial ognized disorder of vellus hair follicles. sections, there was no evidence of sebaceous glands Cutis. 2009;84:295-298. within the cyst wall. The patient was diagnosed with EVHC, and twice daily calcipotriene cream 0.005% was pre- ruptive vellus hair cysts (EVHCs) were initially scribed for the lesions. At the end of the second described by Esterly et al1 in 1977. Although the month of follow-up, a partial response was attained, E disorder is relatively common, it rarely has been with complete resolution of some cysts and flatten- reported in the literature. ing of the remaining lesions (Figure 4).
    [Show full text]
  • Steatocystoma Multiplex: a Case Report of a Rare Disease
    ISSN: 2474-6894 Review Article Mathews Journal of Dermatology Steatocystoma Multiplex: A Case Report of a Rare Disease Diagnosed in a Trauma Patient Adam Kaiser1, Adam Semanoff2, Victor Nannini3, Zachary Chadnick4 1Chief Resident Oral & Maxillofacial Surgery Nassau University Medical Center East Meadow, NY. 2Oral and Maxillofacial Surgery Nassau University Medical Center, East Meadow, NY. 3Faculty Attending, Oral & and Maxillofacial Surgery, Nassau University Medical Center, East Meadow NY. 4Medical Student, American University of the Caribbean School of Medicine. Corresponding Author: Adam C. Kaiser, Chief Resident Oral & Maxillofacial Surgery Nassau University Medical Center East Meadow, NY. Tel: +1 516-572-0123; Email: [email protected] Received Date: 20 Dec 2016 Copyright © 2017 Kaiser AC Accepted Date: 04 Jan 2017 Citation: Kaiser AC, Nannini V, Semanoff A and Chadnick Z. Published Date: 06 Jan 2017 (2017). Steatocystoma Multiplex: A Case Report of a Rare Dis- ease Diagnosed in a Trauma Patient. M J Derm. 2(1): 008. ABSTRACT Purpose:Steatocystoma Multiplex is a rare but benign disease that commonly presents in the head and neck region and has even presented in the oral cavity. Currently, there is limited reference of this condition in oral and maxillofacial surgery literature. The purpose of this article is to report on a rare epithelial disease that occurred in one of our patients and to review other similar diseases. Patient and Methods: A 35-year-old male presented to the Nassau University Medical Center on two separate occasions as a level II and level I trauma, respectively. The patient was referred to our oral and maxillofacial surgery department for the management of his facial trauma and consultation about his associated facial lesions.
    [Show full text]
  • Aars Hot Topics Member Newsletter
    AARS HOT TOPICS MEMBER NEWSLETTER American Acne and Rosacea Society 201 Claremont Avenue • Montclair, NJ 07042 (888) 744-DERM (3376) • [email protected] www.acneandrosacea.org Like Our YouTube Page Visit acneandrosacea.org to Become an AARS Member and TABLE OF CONTENTS Donate Now on Industry News acneandrosacea.org/donate Galderma and Aklief unveil "Me Being Me" campaign ............................................... 2 Ortho Dermatologics opens applications for 2021 Aspire Higher ............................... 2 Our Officers New Medical Research Hidradenitis suppurativa in the pediatric population ................................................... 3 J. Mark Jackson, MD Clinical evaluation of the efficacy of a facial serum .................................................... 4 AARS President Combination of 5-Aminolevulinic acid photodynamic therapy and isotretinoin ........... 4 Zinc(II) complexes of amino acids as new active ingredients ..................................... 5 Andrea Zaenglein, MD Vulvar hidradenitis suppurativa ................................................................................... 5 AARS President-Elect Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa ............ 5 A comparative study between once-weekly and alternating twice-weekly regimen ... 6 Joshua Zeichner, MD Clascoterone: A novel topical androgen receptor inhibitor for the treatment of acne . 6 AARS Treasurer Epithelialized tunnels are a source of inflammation in hidradenitis suppurativa......... 7 Bethanee Schlosser,
    [Show full text]
  • Pachyonychia Congenita-Associated Alopecia
    Hindawi Publishing Corporation Case Reports in Pathology Volume 2012, Article ID 850658, 2 pages doi:10.1155/2012/850658 Case Report Pachyonychia Congenita-Associated Alopecia Azita Nikoo Department of Dermatopathology, Tehran University of Medical Sciences, Tehran, Iran Correspondence should be addressed to Azita Nikoo, [email protected] Received 8 July 2012; Accepted 6 September 2012 Academic Editors: J. S. Khurana and P. Kornprat Copyright © 2012 Azita Nikoo. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. A 5-year-old female, known case of pachyonychia congenita, presented with diffuse hair loss; remaining hairs were easily plucked kinky hairs. Hair samples from patient were investigated using a light microscope. The hairs of the patients were mainly anagen hairs and unlike normal plucked anagen hairs, showed keratinization and cornification of their hair bulbs. No specific hair shaft abnormality was found. 1. Introduction (Figure 2). Hair samples from patient were investigated using ff a light microscope. The hairs were mainly anagen hairs. The Pachyonychia congenita is a rare heritable disease that a ects entire anagen hairs were cornified and showed keratinization the nails, skin, oral and laryngeal mucosae, teeth, and hair and cornification of their hair bulbs. No specific hair shaft [1]. Dominant-negative mutations in four keratin genes abnormality was found (Figure 3). (K6a, K6b, K16, and K17) lead to keratinocyte fragility and the resultant pachyonychia congenita phenotype [2, 3]. Pachyonychia congenita is characterized by hypertrophic 3. Discussion nail dystrophy and associated ectodermal features with There are a few studies about the abnormality of hairs subdivisions that have been suggested based on the clinical features [4].
    [Show full text]
  • Global Development Assistance for Adolescent Health from 2003 to 2015
    Supplementary Online Content Li Z, Li M, Patton GC, Lu C. Global development assistance for adolescent health from 2003 to 2015. JAMA Netw Open. 2018;1(4):e181072. doi:10.1001/jamanetworkopen.2018.1072 eTable 1. List of Donor Countries Included in the CRS eTable 2. 132 Recipients in the CRS (According to the World Health Organization Regions) eTable 3. Key Words to Identify the Related Age Group (Adolescence) in the Creditor Reporting System eTable 4. CRS Purpose Name and Respective Fractions Allocated to Adolescent Health eTable 5. Definitions of DAAH on the Leading Causes of DALYs of Adolescent Health eTable 6. Key Words Used to Search for Projects on Skin and Subcutaneous Diseases in the Creditor Reporting System eTable 7. Key Words Used to Search for Road Injury Projects in the Creditor Reporting System eTable 8. Key Words Used to Search for HIV/AIDS Projects in the Creditor Reporting System eTable 9. Key Words Used to Search for Projects on Iron-Deficiency Anemia in the Creditor Reporting System eTable 10. Key Words Used to Search for Self-Harm Projects in the Creditor Reporting System eTable 11. Key Words Used to Search for Projects on Interpersonal Violence in the Creditor Reporting System eTable 12. Key Words Used to Search for Projects on Depressive Disorders in the Creditor Reporting System eTable 13. Key Words Used to Search for Projects on Lower Back and Neck Pain in the Creditor Reporting System eTable 14. Key Words Used to Search for Diarrheal Projects in the Creditor Reporting System eTable 15. Key Words Used to Search for Tuberculosis Projects in the Creditor Reporting System eTable 16.
    [Show full text]
  • Boards' Fodder
    boards’ fodder Sound-alikes in dermatology by Jeffrey Kushner, DO, and Kristen Whitney, DO Disease Entity Description Actinic granuloma/ Annular elastolytic Variant of granuloma annulare on sun-damaged skin; annular erythematous giant cell granuloma plaques with slightly atrophic center in sun-exposed areas, which may be precipi- tated by actinic damage. Actinic prurigo PMLE-like disease with photodistributed erythematous papules or nodules and hemorrhagic crust and excoriation. Conjunctivitis and cheilitis are commonly found. Seen more frequently in Native Americans (especially Mestizos). Actinomycetoma “Madura Foot”; suppurative infection due to Nocaria, Actinomadura, or Streptomyces resulting in tissue tumefaction, draining sinuses and extrusion of grains. Actinomycosis “Lumpy Jaw”; Actinomyces israelii; erythematous nodules at the angle of jaw leads to fistulous abscess that drain purulent material with yellow sulfur granules. Acrokeratosis verruciformis Multiple skin-colored, warty papules on the dorsal hands and feet. Often seen in conjunction with Darier disease. Acrodermatitis enteropathica AR; SLC39A4 mutation; eczematous patches on acral, perineal and periorificial skin; diarrhea and alopecia; secondary to zinc malabsorption. Atrophoderma 1) Atrophoderma vermiculatum: Pitted atrophic scars in a honeycomb pattern around follicles on the face; associated with Rombo, Nicolau-Balus, Tuzun and Braun-Falco-Marghescu syndromes. 2) Follicular atrophoderma: Icepick depressions at follicular orifices on dorsal hands/feet or cheeks; associated with Bazex-Dupré-Christol and Conradi- Hünermann-Happle syndromes. 3) Atrophoderma of Pasini and Pierini: Depressed patches on the back with a “cliff-drop” transition from normal skin. 4) Atrophoderma of Moulin: Similar to Pasini/Pierini, except lesions follow the lines of Blaschko. Anetoderma Localized area of flaccid skin due to decreased or absent elastic fibers; exhibits “buttonhole” sign.
    [Show full text]
  • Buffalo Medical Group, P.C. Robert E
    Buffalo Medical Group, P.C. Robert E. Kalb, M.D. Phone: (716) 630-1102 Fax: (716) 633-6507 Department of Dermatology 325 Essjay Road Williamsville, New York 14221 2 FOOT- 1 HAND SYNDROME 2 foot - 1 hand syndrome is a superficial infection of the skin caused by the common athlete's foot fungus. It is quite common for people to have a minor amount of an athlete's foot condition. This would appear as slight scaling and/or itching between the toes. In addition, patients may have thickened toenails as part of the athlete's foot condition. Again the problem on the feet is very common and often patients are not even aware of it. In some patients, however, the athlete's foot fungus can spread to another area of the body. For some strange and unknown reason, it seems to affect only one hand. That is why the condition is called 2 foot - 1 hand syndrome. It is not clear why the problem develops in only one hand or why the right or left is involved in some patients. Fortunately there is very effective treatment to control this minor skin problem. If the problem with the superficial fungus infection is confined to the skin, then a short course of treatment with an oral antibiotic is all that is required. This antibiotic is very safe and normally clears the skin up fairly rapidly. It is often used with a topical cream to speed the healing process. If, however, the fingernails of the affected hand are also involved then a more prolonged course of the antibiotic will be necessary.
    [Show full text]